Feasibility of Implementing the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in a Multicenter Trial: NCCTG N1048

被引:52
|
作者
Basch, Ethan [1 ,3 ]
Dueck, Amylou C. [4 ]
Rogak, Lauren J. [3 ]
Mitchell, Sandra A. [5 ]
Minasian, Lori M. [5 ]
Denicoff, Andrea M. [5 ]
Wind, Jennifer K. [6 ]
Shaw, Mary C. [3 ]
Heon, Narre [3 ]
Shi, Qian [7 ]
Ginos, Brenda [4 ]
Nelson, Garth D. [7 ]
Meyers, Jeffrey P. [7 ]
Chang, George J. [8 ]
Mamon, Harvey J. [6 ]
Weiser, Martin R. [3 ]
Kolevska, Tatjana [9 ]
Reeve, Bryce B. [2 ]
Bruner, Deborah Watkins [10 ]
Schrag, Deborah [6 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, 170 Manning Dr, Chapel Hill, NC 27516 USA
[2] Duke Univ, Med Ctr, Duke Canc Inst, Durham, NC USA
[3] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[4] Mayo Clin, Alliance Stat & Data Ctr, Scottsdale, AZ USA
[5] NCI, Rockville, MD USA
[6] Dana Farber Partners CancerCare, Boston, MA USA
[7] Mayo Clin, Alliance Stat & Data Ctr, Rochester, MN USA
[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[9] Kaiser Permanente Vallejo Med Ctr, Vallejo, CA USA
[10] Emory Univ, Atlanta, GA 30322 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1200/JCO.2018.78.8620
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe US National Cancer Institute (NCI) Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed to enable patient reporting of symptomatic adverse events in oncology clinical research. This study was designed to assess the feasibility and resource requirements associated with implementing PRO-CTCAE in a multicenter trial.MethodsPatients with locally advanced rectal cancer enrolled in the National Cancer Institute-sponsored North Central Cancer Treatment Group (Alliance) Preoperative Radiation or Selective Preoperative Radiation and Evaluation before Chemotherapy and Total Mesorectal Excision trial were asked to self-report 30 PRO-CTCAE items weekly from home during preoperative therapy, and every 6 months after surgery, via either the Web or an automated telephone system. If participants did not self-report within 3 days, a central coordinator called them to complete the items. Compliance was defined as the proportion of participants who completed PRO-CTCAE assessments at expected time points.ResultsThe prespecified PRO-CTCAE analysis was conducted after the 500th patient completed the 6-month follow-up (median age, 56 years; 33% female; 12% nonwhite; 43% high school education or less; 5% Spanish speaking), across 165 sites. PRO-CTCAE was reported by participants at 4,491 of 4,882 expected preoperative time points (92.0% compliance), of which 3,771 (77.2%) were self-reported by participants and 720 (14.7%) were collected via central coordinator backup. Compliance at 6-month post-treatment follow-up was 333 of 468 (71.2%), with 122 (26.1%) via backup. Site research associates spent a median of 15 minutes on PRO-CTCAE work for each patient visit. Work by a central coordinator required a 50% time commitment.ConclusionHome-based reporting of PRO-CTCAE in a multicenter trial is feasible, with high patient compliance and low site administrative requirements. PRO-CTCAE data capture is improved through centralized backup calls.
引用
收藏
页码:3120 / +
页数:10
相关论文
共 50 条
  • [1] PROceeding With the Patient-Reported Outcomes (PROs) Version of the Common Terminology Criteria for Adverse Events
    Movsas, Benjamin
    JAMA ONCOLOGY, 2015, 1 (08) : 1059 - 1060
  • [2] Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events
    Reeve, Bryce B.
    McFatrich, Molly
    Mack, Jennifer W.
    Maurer, Scott H.
    Jacobs, Shana S.
    Freyer, David R.
    Withycombe, Janice S.
    Baker, Justin N.
    Castellino, Sharon M.
    Lin, Li
    Lucas, Nicole R.
    Hinds, Pamela S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2020, 112 (11): : 1143 - 1152
  • [3] Development of the US NCI patient-reported outcomes version of the common terminology criteria for adverse events
    Dueck, Amylou C.
    Basch, Ethan
    Mitchell, Sandra A.
    ANNALS OF ONCOLOGY, 2015, 26 : 26 - 26
  • [4] Responsiveness of Items from the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events
    Dueck, Amylou C.
    Mitchell, Sandra A.
    Mendoza, Tito R.
    Bennett, Antonia V.
    Rogak, Lauren
    Atkinson, Thomas M.
    Li, Yuelin
    Reeve, Bryce B.
    Basch, Ethan
    QUALITY OF LIFE RESEARCH, 2014, 23 : 37 - 38
  • [5] Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial
    Basch, Ethan
    Pugh, Stephanie L.
    Dueck, Amylou C.
    Mitchell, Sandra A.
    Berk, Lawrence
    Fogh, Shannon
    Rogak, Lauren J.
    Gatewood, Marcha
    Reeve, Bryce B.
    Mendoza, Tito R.
    O'Mara, Ann M.
    Denicoff, Andrea M.
    Minasian, Lori M.
    Bennett, Antonia V.
    Setser, Ann
    Schrag, Deborah
    Roof, Kevin
    Moore, Joan K.
    Gergel, Thomas
    Stephans, Kevin
    Rimner, Andreas
    DeNittis, Albert
    Bruner, Deborah Watkins
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 98 (02): : 409 - 418
  • [6] Recommended scoring approach for the pediatric patient-reported outcomes version of the Common Terminology Criteria for Adverse Events
    Hinds, Pamela S.
    Pinheiro, Laura C.
    McFatrich, Molly
    Waldron, Mia
    Baker, Justin N.
    Mowbray, Catriona
    Maurer, Scott H.
    Cheng, Yao
    Reeve, Bryce B.
    Wang, Jichuan
    PEDIATRIC BLOOD & CANCER, 2022, 69 (06)
  • [7] Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
    Yang, Shan-Shan
    Chen, Lei
    Liu, Ying
    Lu, Hai-Jun
    Huang, Bo-Jie
    Lin, Ai-Hua
    Sun, Ying
    Ma, Jun
    Xie, Fang-Yun
    Mao, Yan-Ping
    BMC CANCER, 2021, 21 (01)
  • [8] Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
    Shan-Shan Yang
    Lei Chen
    Ying Liu
    Hai-Jun Lu
    Bo-Jie Huang
    Ai-Hua Lin
    Ying Sun
    Jun Ma
    Fang-Yun Xie
    Yan-Ping Mao
    BMC Cancer, 21
  • [9] Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure
    Reeve, Bryce B.
    McFatrich, Molly
    Lin, Li
    Lucas, Nicole R.
    Mack, Jennifer W.
    Jacobs, Shana S.
    Withycombe, Janice S.
    Baker, Justin N.
    Freyer, David R.
    Hinds, Pamela S.
    CANCER, 2021, 127 (09) : 1483 - 1494
  • [10] Patient-reported outcomes in PROSPECT trial (Alliance N1048) - FOLFOX is not a panacea
    O'Cathail, Sean M.
    Adams, Richard
    Hawkins, Maria A.
    Sebag-Montefiore, David
    Marijnen, Corrie A. M.
    Fokas, Emmanouil
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 43